Mien Van Hoang

1.0k total citations
19 papers, 841 citations indexed

About

Mien Van Hoang is a scholar working on Molecular Biology, Cell Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mien Van Hoang has authored 19 papers receiving a total of 841 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 4 papers in Cell Biology and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mien Van Hoang's work include Angiogenesis and VEGF in Cancer (4 papers), Retinal Diseases and Treatments (3 papers) and Signaling Pathways in Disease (3 papers). Mien Van Hoang is often cited by papers focused on Angiogenesis and VEGF in Cancer (4 papers), Retinal Diseases and Treatments (3 papers) and Signaling Pathways in Disease (3 papers). Mien Van Hoang collaborates with scholars based in United States, United Kingdom and Japan. Mien Van Hoang's co-authors include Donald R. Senger, Mary C. Whelan, Janice A. Nagy, Anthony J. Turner, Huiyan Zeng, Harold F. Dvorak, LiuLiang Qin, Lawrence F. Brown, Dezheng Zhao and Lois E. H. Smith and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.

In The Last Decade

Mien Van Hoang

19 papers receiving 833 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mien Van Hoang United States 15 526 170 160 155 136 19 841
Kazumi Hayashi Japan 14 521 1.0× 172 1.0× 157 1.0× 55 0.4× 193 1.4× 33 958
Rodica Stancou France 13 613 1.2× 202 1.2× 100 0.6× 166 1.1× 196 1.4× 17 935
Éric Lacazette France 18 914 1.7× 112 0.7× 117 0.7× 124 0.8× 175 1.3× 34 1.3k
Jean Kloss United States 14 645 1.2× 161 0.9× 57 0.4× 201 1.3× 178 1.3× 21 1.1k
Neil A. Taylor United Kingdom 12 580 1.1× 179 1.1× 62 0.4× 320 2.1× 275 2.0× 15 1.1k
Xianghu Qu United States 15 916 1.7× 72 0.4× 64 0.4× 104 0.7× 173 1.3× 26 1.2k
Gábor Sirokmány Hungary 14 538 1.0× 153 0.9× 32 0.2× 186 1.2× 87 0.6× 17 867
Ari‐Pekka J. Huovila Finland 8 543 1.0× 117 0.7× 92 0.6× 103 0.7× 241 1.8× 8 975
Raudel Sandoval United States 13 504 1.0× 184 1.1× 73 0.5× 227 1.5× 137 1.0× 15 1.0k
Hans‐Christian Aasheim Norway 22 736 1.4× 275 1.6× 369 2.3× 252 1.6× 153 1.1× 40 1.2k

Countries citing papers authored by Mien Van Hoang

Since Specialization
Citations

This map shows the geographic impact of Mien Van Hoang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mien Van Hoang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mien Van Hoang more than expected).

Fields of papers citing papers by Mien Van Hoang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mien Van Hoang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mien Van Hoang. The network helps show where Mien Van Hoang may publish in the future.

Co-authorship network of co-authors of Mien Van Hoang

This figure shows the co-authorship network connecting the top 25 collaborators of Mien Van Hoang. A scholar is included among the top collaborators of Mien Van Hoang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mien Van Hoang. Mien Van Hoang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
MORI, Takahiro, et al.. (2025). A Ketone‐Accepting Pictet–Spenglerase for the Asymmetric Construction of 1,1‐Disubstituted Tetrahydro‐ß‐carboline Alkaloids. Angewandte Chemie International Edition. 64(25). e202502367–e202502367. 2 indexed citations
2.
Al‐Moujahed, Ahmad, Bo Tian, Nikolaos E. Efstathiou, et al.. (2019). Receptor interacting protein kinase 3 (RIP3) regulates iPSCs generation through modulating cell cycle progression genes. Stem Cell Research. 35. 101387–101387. 13 indexed citations
3.
Efstathiou, Nikolaos E., Mien Van Hoang, Shoji Notomi, et al.. (2018). Issues with the Specificity of Immunological Reagents for NLRP3: Implications for Age-related Macular Degeneration. Scientific Reports. 8(1). 461–461. 42 indexed citations
4.
5.
Brodowska, Katarzyna, Sofia Theodoropoulou, Melissa Meyer zu Hörste, et al.. (2014). Effects of metformin on retinoblastoma growth in vitro and in vivo. International Journal of Oncology. 45(6). 2311–2324. 19 indexed citations
6.
Sakurai, Kazuo, et al.. (2014). DNA methylation and chromatin dynamics in embryonic stem cell regulation. 3 indexed citations
7.
Hoang, Mien Van, Lois E. H. Smith, & Donald R. Senger. (2010). Moderate GSK-3β inhibition improves neovascular architecture, reduces vascular leakage, and reduces retinal hypoxia in a model of ischemic retinopathy. Angiogenesis. 13(3). 269–277. 25 indexed citations
8.
Hoang, Mien Van, Janice A. Nagy, Joan E.B. Fox, & Donald R. Senger. (2010). Moderation of Calpain Activity Promotes Neovascular Integration and Lumen Formation during VEGF-Induced Pathological Angiogenesis. PLoS ONE. 5(10). e13612–e13612. 29 indexed citations
9.
Hoang, Mien Van, Lois E. H. Smith, & Donald R. Senger. (2010). Calpain inhibitors reduce retinal hypoxia in ischemic retinopathy by improving neovascular architecture and functional perfusion. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1812(4). 549–557. 39 indexed citations
10.
Hoang, Mien Van, Janice A. Nagy, & Donald R. Senger. (2010). Cdc42-mediated inhibition of GSK-3β improves angio-architecture and lumen formation during VEGF-driven pathological angiogenesis. Microvascular Research. 81(1). 34–43. 37 indexed citations
11.
Hoang, Mien Van, Janice A. Nagy, & Donald R. Senger. (2010). Active Rac1 improves pathologic VEGF neovessel architecture and reduces vascular leak: mechanistic similarities with angiopoietin-1. Blood. 117(5). 1751–1760. 41 indexed citations
12.
Zeng, Huiyan, LiuLiang Qin, Dezheng Zhao, et al.. (2006). Orphan nuclear receptor TR3/Nur77 regulates VEGF-A–induced angiogenesis through its transcriptional activity. The Journal of Experimental Medicine. 203(3). 719–729. 133 indexed citations
13.
Qin, LiuLiang, Dezheng Zhao, Xin Liu, et al.. (2006). Down Syndrome Candidate Region 1 Isoform 1 Mediates Angiogenesis through the Calcineurin-NFAT Pathway. Molecular Cancer Research. 4(11). 811–820. 65 indexed citations
14.
Zeng, Huiyan, LiuLiang Qin, Dezheng Zhao, et al.. (2006). Orphan nuclear receptor TR3/Nur77 regulates VEGF-A–induced angiogenesis through its transcriptional activity. The Journal of Cell Biology. 172(7). i15–i15. 2 indexed citations
15.
Hoang, Mien Van, Mary C. Whelan, & Donald R. Senger. (2004). Rho activity critically and selectively regulates endothelial cell organization during angiogenesis. Proceedings of the National Academy of Sciences. 101(7). 1874–1879. 173 indexed citations
16.
Bax, Daniel V., Anthea Messent, Jonathan Tart, et al.. (2004). Integrin α5β1 and ADAM-17 Interact in Vitro and Co-localize in Migrating HeLa Cells. Journal of Biological Chemistry. 279(21). 22377–22386. 69 indexed citations
17.
Hoang, Mien Van & Donald R. Senger. (2004). In Vivo and In Vitro Models of Mammalian Angiogenesis. Humana Press eBooks. 294. 269–286. 15 indexed citations
18.
Sansom, Clare, Mien Van Hoang, & Anthony J. Turner. (1998). Molecular modelling and site-directed mutagenesis of the active site of endothelin-converting enzyme. Protein Engineering Design and Selection. 11(12). 1235–1241. 23 indexed citations
19.
Hoang, Mien Van & Anthony J. Turner. (1997). Novel activity of endothelin-converting enzyme: hydrolysis of bradykinin. Biochemical Journal. 327(1). 23–26. 89 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026